FLASH NEWS LIVE

US FDA review boosts odds for Wockhardt’s NCE success story: Vishal Manchanda

US FDA review boosts odds for Wockhardt’s NCE success story: Vishal Manchanda

Wockhardt’s breakthrough respiratory drug Zaynich moves a step closer to market as the US FDA accepts it for review, boosting approval odds and keeping the company on track for its mid-2026 launch target. Equity analyst Vishal Manchanda says the priority revi…

Read Full Article →

Read more

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp